---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-302630"
form_type: "8-K"
ticker: "HTGC"
cik: "0001280784"
company_name: "Hercules Capital, Inc."
filed_at: "2021-10-20T23:59:59+00:00"
generated_at: "2026-06-28T19:33:14.049369+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Hercules Capital appoints Pam Randhawa to board, effective Nov 1, 2021

## Summary
- Ms. Randhawa will serve as a Class I director with term expiring in 2023.
- She will serve on the Nominating and Corporate Governance Committee.
- She brings over 20 years of healthcare/life sciences experience; currently CEO/Founder of Empiriko Corporation.
- She will receive standard director compensation including annual retainer and restricted stock awards.

## SEC filing metadata
- accession: 0001193125-21-302630
- form_type: 8-K
- ticker: HTGC
- cik: 0001280784
- company_name: Hercules Capital, Inc.
- filed_at: 2021-10-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1280784/000119312521302630/0001193125-21-302630-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1280784/000119312521302630/d244305d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-302630
- JSON: https://secwatch.observer/filing/0001193125-21-302630.json
- Plain text: https://secwatch.observer/filing/0001193125-21-302630.txt

## Key facts
- Executive change
  Pam Randhawa was appointed as director at Hercules Capital, Inc..
  - Action: appointed
  - Role: director
  source text: On October 20, 2021, the Board of Directors of the Company appointed Pam Randhawa as a director of the Company, effective November 1, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1280784/000119312521302630/0001193125-21-302630-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.